...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: plenty of scenarios being put out there...

PVLee,

I remember Masila's note. However, it doesn nothing to help alleviate the current confusion of the Reorganization Resolution. The numerous scenarios that different posters have come up with attest to the confusion that currently exists.

BearDownAZ

Share
New Message
Please login to post a reply